Candriam SCA’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-92,186
| Closed | -$322K | – | 919 |
|
|
2022
Q4 | $322K | Sell |
92,186
-82,419
| -47% | -$288K | ﹤0.01% | 835 |
|
|
2022
Q3 | $6.46M | Buy |
174,605
+32,419
| +23% | +$1.2M | 0.05% | 342 |
|
|
2022
Q2 | $2.7M | Buy |
142,186
+6,510
| +5% | +$124K | 0.02% | 436 |
|
|
2022
Q1 | $3.66M | Buy |
+135,676
| New | +$3.66M | 0.02% | 408 |
|